Web seminar recordings

QIAGEN Clinical Insight (QCI) Interpret identifies targeted therapy and clinical trials in hematological tumors

December 08, 2016
Hematological malignancies originating from hematopoietic and lymphoid tissue are complex heterogeneous diseases characterized by distinct clinicopathological features and molecular alterations. The heterogeneity of leukemia and lymphoma has presented massive challenges for identifying the appropriate treatment for each patient. Advances in next-generation sequencing (NGS) have presented unique treatment opportunities beyond standard of care and chemotherapy. QIAGEN® Clinical Insight (QCI™ Interpret) is a web-based application for the annotation, classification, and reporting of clinically actionable variants from NGS data in clinical genomics laboratories.

Interested in learning more?

Click here

Related videos

Web seminar recordings

Translational research: Find the needle in the haystack and access trustworthy knowledge of known...

297 views December 15, 2020

Get connected to the industry’s most comprehensive collection of biological...

Web seminar recordings

More effective and efficient routine testing for somatic analysis and interpretation – a live...

258 views October 29, 2020

See why laboratories across the globe choose QIAGEN solutions for routine...

Web seminar recordings

Clinical Metagenomics for Rapid Detection of Enteric Pathogens and Characterization of the...

1,613 views December 20, 2016

High-throughput sequencing, combined with high-resolution metagenomic...